Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Boston Scientific

140 women win payouts for vaginal mesh complications

Women claimed the implants caused infection, bleeding, chronic pain, bladder and bowel perforations, and problems urinating

The Independent UK

140 women in England receive payout for vaginal mesh implant complications

Settlement from first successful group claim in England expected to total millions of pounds, but size of payments unknown

The Guardian - UK

What Are Wall Street Analysts' Target Price for Boston Scientific Stock?

Boston Scientific has outperformed the broader market over the past year, and analysts remain bullish about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

How Boston Scientific's digital and IT boss upgraded her team from order takers to strategic thinkers

The $110 billion medical devices company now has a digital leader who sits on the executive management board of every division, every region, and every business function.

Fortune

Stock Market Diverges, With Tesla, Google, ServiceNow, GE In Focus: Weekly Review

The stock market remained split, with small caps leading and the Nasdaq tumbling, led by Google and Tesla.

Investors Business Daily

Boston Sci Slumps After One Key Segment Drives Its Second-Quarter Beat

Boston Scientific stock slumped Wednesday despite a "big organic revenue beat" driven by strong electrophysiology sales, one analyst said.

Investors Business Daily

Boston Scientific's Quarterly Earnings Preview: What You Need to Know

Boston Scientific is expected to report its second-quarter earnings results this month, and Wall Street analysts expect a single-digit profit growth.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Silk Road Medicine Rockets On Boston Scientific's $1.16 Billion Takeover

Silk stock skyrocketed Tuesday after Boston Scientific agreed to buy the medical devices company for $1.16 billion.

Investors Business Daily

Is Boston Scientific Stock Outperforming the S&P 500?

Boston Scientific recently reached an all-time high, outperforming the S&P 500 Index, with Wall Street analysts remaining bullish about the stock’s prospects.

Barchart

Boston Scientific Stock: Is Wall Street Bullish or Bearish?

Boston Scientific has significantly outperformed the broader market YTD, and Wall Street analysts are still bullish about the stock’s prospects.

Barchart

The Bullish First-Quarter Report That Helped Boston Scientific Break Out — Twice

Boston Scientific made a bullish move Wednesday morning, topping two buy points on a solid first-quarter report.

Investors Business Daily

3 Safe Haven Stocks to Own in an Unpredictable Market

Even though 2024 kicked off strong, recent macroeconomic uncertainties highlight the need for resilient investments. These three “safe haven” stocks are worth considering for hedging against the market downswings.

Barchart

Boston Scientific Surges To A Record On Its 'Impressive' First-Quarter Guidance

Boston Scientific's first-quarter sales guidance is "impressive," an analyst said Wednesday as BSX stock hit a record high.

Investors Business Daily

Stryker, Boston Scientific Score Earnings Beats, Extend Breakouts

Shares of Stryker, Boston Scientific jumped early Wednesday after healthy earnings beats and price target hikes from analysts.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

Smith & Nephew (SNN) vs. Boston Scientific (BSX): Buy or Sell as These Medical Stocks Gear up for Quarterly Earnings?

The medical devices and equipment industry is primed to make significant strides toward growth this year, a surge propelled by increasing incidences of chronic diseases and the emphasis on early detection and treatment, coupled with leaps in technological development. Given this backdrop, let’s compare medical device stocks Boston Scientific (BSX)…

Barchart

Chart of the Day: Boston Scientific - Revenue Growth Potential

The Chart of the Day belongs to the healthcare company Boston Scientific (BSX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

Barchart

Chart of the Day: Boson Scientific - Revenue Growth Potential

Investors Business Daily

Ambrx Snags $2 Billion Takeover, But CEO Dan O'Connor Says Don't Call It 'Hot'

Cancer-focused biotech companies Ambrx and Harpoon snapped up a pair of takeover deals. AMAM stock and HARP stock soared.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Markets Today: Stocks Climb on M&A Activity and Lower Bond Yields

Morning Markets March E-Mini S&P 500 futures (ES H24) are up +0.06%, and March Nasdaq 100 E-Mini futures (NQH2 4) are up +0.18%. Stock index futures this morning are moderately higher. An increase in M&A activity supports stocks after Boston Scientific agreed to buy Axionics for $3.7 billion and Johnson...

Investors Business Daily

Boston Scientific, Edwards Lifesciences Tumble As Guidance 'Noise' Slams The Latter

Boston Scientific beat third-quarter expectations, but Edwards Lifesciences' metrics were just in line. Shares of both tumbled.

Barchart

3 Top-Rated Growth Stocks To Buy on Every Dip

Growth stocks are down, but don't count them out. Here are three top-rated names worth scooping up when the market pulls back.

Investors Business Daily

Boston Scientific Stock Sees IBD RS Rating Improve To 74

A Relative Strength Rating upgrade for Boston Scientific shows improving technical performance. Will it continue?

Investors Business Daily

Stock Market Falls Into Correction On Hawkish Fed: Weekly Review

A market correction has taken hold as Treasury yields surged to long-term highs on a hawkish Fed outlook.

Investors Business Daily

Boston Scientific Offers Bullish Guidance And Briefly Breaks Out

Boston Scientific kicked off its Investor Day on Wednesday, a day after announcing its Relievant buyout, and BSX stock jumped.

Investors Business Daily

Boston Scientific Surges As It Looks To Enter A Market Worth Nearly $8 Billion

Boston Scientific is likely to win FDA approval for a new method of treating abnormal heartbeats. BSX stock surged on its Phase 3 win.

1 2 3 4

People

Sristi Suman JayaswalThe

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.